Abstract: The transcription factor GATA-2 is expressed in hematopoietic stem and progenitor cells and is functionally implicated in their survival and proliferation. In the present study, we show that GATA-2 exists as an acetylated protein in immature precursor cells, KG1. GATA-2 was acetylated in vitro by p300 and GCN5. We have identified multiple acetylation sites by p300 on GATA-2, which include sites outside the zinc finger domain. We confirmed that GATA-2 acetylation occurred in transiently transfected 293T cells at sites similar to those induced by p300 in vitro. We have successfully shown that acetylation of GATA-2 in vitro increased its DNA-binding activity. In addition, GATA-2 displayed a transcriptional synergism with p300 that was impaired by mutation of each acetylation site. More importantly, each mutation in the acetylation sites of GATA-2 abolished its growth inhibitory effect on an interleukin-3-dependent progenitor, 32D. We conclude that acetylation provides multiple control points for the regulation of GATA-2 function. J. Leukoc. Biol. 75: 529 -540; 2004.
INTRODUCTION
Post-translational acetylation of histones has long been correlated with transcriptional activation [1, 2] . Acetylation neutralizes the positive charge associated with the ε amino groups of lysine residues, thereby loosening contacts between the histones and negatively charged DNA. Increased histone acetylation also promotes chromatin decompaction [3] . Both of these effects can increase transactivator binding to nucleosomal DNA, facilitating transcriptional activation. Proteins that possess such histone acetyltransferase (HAT) activity include p300, cyclic AMP response element-binding protein-binding protein (CBP), GCN5, p300/CBP-associated factor (P/CAF), TATA element-binding protein-associated factor (TAF)II250, steroid receptor coactivator-1, and activator of thyroid and retinoic acid receptors (ACTR) [4 -11] . These HATs have different lysine specificities, and some of them form complexes with each other in acetylating histones [6, 9, 11] . It is interesting that recent studies demonstrate that these acetyltransferases have substrates in addition to nucleosomal histones, such as tumor suppressor protein p53 for p300 and P/CAF [12, 13] , the erythroid Kruppel-like factor (EKLF) for p300 and CBP [14] , the Kruppel-like zinc finger transcription factor specificity protein 1 (Sp1) for p300 [15] , the basal transcription factors TFIIE, TFIIF for p300, CBP, P/CAF, and TAFII250 [16] , cell-cycle regulator E2F1 for P/CAF, p300, and CBP [17] , proto-oncogene product c-Myb for p300, CBP, and GCN5 [18, 19] , the orphan nuclear receptor hepatocyte nuclear factor-4 (HNF-4) for CBP [20] , and hematopoietic lineage-specific factor GATA-1 and GATA-3 for p300 and CBP [21] [22] [23] . Acetylation has been shown to regulate the function of these factors at multiple levels such as DNA-binding activity, protein interaction, nuclear localization, protein stability, and transactivation activity. These findings provide additional insights into the regulation of transcription factor by post-translational modification. However, the physiological and biological significance of acetylating, nonhistone proteins mostly remains an open question.
Members of the GATA family proteins play critical roles in cellular proliferation and differentiation of various cell lineages [24, 25] . Three GATA family members (GATA-1/2/3) have been identified as important regulators of gene expression in hematopoietic cells. Gene targeting experiments have demonstrated an essential role for GATA-1 in erythroid and megakaryocytic lineage differentiation [26] , GATA-2 in the survival and growth of multipotential progenitors and mast cell development [27] , and GATA-3 in T cell development and differentiation [28] . These factors bind to a DNA consensus sequence (T/A)GATA(A/G) using a highly conserved DNAbinding domain composed of amino-and carboxy-terminal zinc fingers [29] . Much attention has been focused on how these different factors, which seemingly bind to similar (or identical) cis elements, carry out their distinct, biological functions. Part of the answer may be attributed to their different expression profiles: GATA-1 is highly expressed in developing erythroid cells, mast cells, and megakaryocytes [30, 31] . GATA-2 is also expressed in early erythroid cells, mast cells, and megakaryocytes [32] [33] [34] [35] , but particularly high levels of expression have been observed in enriched populations of pluripotent hemato-poietic stem cells [36] . The expression of GATA-3 within hematopoiesis is confined to definitive erythroid cells and T lymphocytes [24, 37] . Functional experiments, in which part of the deficiency caused by loss of function of a given GATA family member is rescued by enforced expression of a different family member, support the notion that GATA factors are partially interchangeable [38, 39] . However, the rescue is yet to be completely effective, thereby implying the existence of intrinsic differences in the functional potentials of the different GATA factors. That there are such intrinsic differences in the biological properties of different GATA factors has also been argued on the basis of ectopic expression experiments conducted in erythroid cells [40] and multipotent progenitor cells [41, 42] . Such differences may relate to subtle differences in binding-site affinities or preferences. Some evidence for this has been obtained in vitro [43] [44] [45] , but how these findings relate to the in vivo situation will require a fuller understanding of different bona fide GATA target genes.
Modifications of GATA proteins, through phosphorylation [46, 47] and acetylation [21] [22] [23] , provide additional control points for the regulation of GATA factor functions. GATA-1 acetylation occurs at two highly conserved, lysine-rich motifs near the zinc finger domains by p300/CBP. Acetylation of GATA-1 enhances transactivation capacity and is required for its biological function, the induction of erythroid differentiation, although its effect on DNA-binding activity is still unconfirmed [21, 22] . Conversely, nothing is known about acetylation of GATA-2. In the present study, we show that GATA-2 exists as an acetylated protein in vivo that is also acetylated in vitro by p300 and GCN5. We have identified multiple acetylation sites in the native GATA-2, which include sites outside the zinc finger domain. We have successfully shown that GATA-2 protein acetylated by p300 in vitro exhibited an increase in DNA-binding activity. We also showed a transcriptional synergism of GATA-2 with p300 in transfected cells that was impaired by mutation of the acetylated lysines. More importantly, those acetylation-defective mutations of GATA-2 abolished the growth-inhibiting effect of wild-type GATA-2 on interleukin (IL)-3-dependent myeloid cells. We conclude that acetylation appears to significantly affect the biological function of GATA-2.
MATERIALS AND METHODS

Cells
The myeloid progenitor cells, KG1, were cultured in RPMI 1640, supplemented with 10% fetal calf serum (FCS). A human kidney epithelial cell line, 293T, was maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% FCS. The IL-3-dependent early myeloid progenitor cells, 32D, were cultured in RPMI 1640 supplemented with 10% FCS in the presence of 5 ng/mL recombinant murine IL-3, kindly provided by the Kirin Brewery Co. (Santa Monica, CA).
Antibodies
Antiflag M2 monoclonal antibody, antiglutathione S-transferase (GST) antibody, and anti-His express antibody were purchased from Kodak-IBI (Rochester, NY), Pharmacia (Uppsala, Sweden), and Invitrogen (Carlsbad, CA), respectively. Rabbit polyclonal anti-GATA-2 antibody (H-116) and mouse monoclonal anti-GATA-2 antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Plasmids
GST-GATA-2/pGEX for expression of GST-fused, full-length GATA-2 was as described [48] . GST-GATA-2(1-197)/pGEX, GST-GATA-2(198-393)/pGEX, and GST-GATA-2(393-480)/pGEX for GST-fused partial fragment of GATA-2 [amino acids (aa) 1-197, aa 198 -393 , and aa 393-480, respectively] were constructed using digestion and ligation at convenient restriction sites. Lysineto-alanine substitution on these GST constructs was performed using overlapping polymerase chain reaction (PCR). Sequence analysis confirmed the absence of PCR errors using ABI 310 autosequencer (Perkin Elmer, Wellesley, MA). GST-p300 -HAT/pGEX and GST-GCN5/pGEX for expression of GSTfused HAT domain of p300 (aa 1053-1810) and full-length GCN5 (aa 1-476), respectively, were made by PCR cloning as described previously [18] . Hisp300 -HAT/pCDNA was constructed by digestion of corresponding GST constructs and insertion into the His/pCDNA expression vector (Invitrogen).
Flag-GATA-2/promoter cytomegalovirus (pCMV) and His-GATA-2/ pCDNA for expression of Flag-tagged and His-tagged, full-length GATA-2 and the constructs for its lysine-to-alanine substituted mutants were constructed by digestion of corresponding GST-GATA-2 constructs and insertion into the Flag/pCMV expression vector (Kodak-IBI) and His/pCDNA expression vector, respectively. EFG2ERP, a kind gift from Stuart H. Orkin (Harvard Medical School, Cambridge, MA), expresses GATA-2/estrogen receptor (ER), an inframe fusion protein of GATA-2, and the ligand-binding domain of estrogen (aa 282-595). The full-length cDNAs of GATA-2/ER were cloned into a His/ pCDNA expression vector to make His-GATA-2/ER/pCDNA for expression of His-tagged GATA-2/ER. The digestion of corresponding mutant Flag-GATA-2 constructs and recombination into His-GATA-2/ER/pCDNA constructed mutant constructs with lysine-to-alanine mutations.
In vitro acetylation assays
GST and GST fusion proteins were expressed in Escherichia coli strain BL21 and purified with glutathione beads (Pharmacia), according to the manufacturer's instructions. Acetyltransferase assays were performed as described [18] with a slight modification. Briefly, 1 g wild-type or mutant GST-GATA-2 was incubated at 37°C for 1 h with 100 ng GST or GST-fused acetyltransferases and 1 l [ 14 C]acetyl-CoA (CoA; 50 mCi/mmol; Amersham, Little Chalfont, UK) in 30 l acetyltransferase reaction buffer [50 mM Tris-HCl (pH 8.0), 5% glycerol, 1 mM dithiothreitol, and 10 mM sodium butyrate]. The reaction mixture was subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by image analyzing using a BAS 2000 image analyzer (Fuji Film, Tokyo, Japan).
In vivo acetylation assays
293T cells (5ϫ10 5 ) were transfected with the indicated expression plasmids by lipofectamine 2000 (Gibco BRL, Grand Island, NY) according to the manufacturer's instructions. Total amounts of plasmids used for transfection were equalized by the addition of corresponding empty vectors. Forty-eight hours after transfection, the medium was replaced with DMEM supplemented with 10% FCS in the presence of 0.05 mCi/ml sodium [ 14 C]acetate (Amersham) for 4 h. Cells were then lysed and immunoprecipitated with M2 antibody-conjugated agarose followed by SDS-PAGE and subsequent image analyzing. KG1 cells (3ϫ10 7 ) were also pulse-labeled with RPMI 1640, supplemented with 10% FCS in the presence of 0.05 mCi/ml sodium [ 14 C]acetate for 4 h. Nuclear extracts obtained from the cells were subjected to immunoprecipitation with anti-GATA-2 antibody followed by SDS-PAGE and image analyzing.
DNA-binding reactions
Electrophoretic mobility shift assay using 5Ј-AGTCCATCTGATAAGACT-TATCTGCTGCCC-3Ј as probe was performed as described previously [48] . Anti-GST antibody was used for supershift assay.
Luciferase assays
A luciferase reporter plasmid 8ϫ GATA-R⌭ P36 that contains eight GATA consensus motifs was a kind gift from Michael G. Rosenfeld (University of California at San Diego). 293T cells (1ϫ10 5 ) were transfected with the indi-cated expression plasmids using lipofectamine 2000. Total amounts of plasmids used for transfection were equalized by the addition of corresponding empty vectors. Luciferase activities were assayed using a luciferase assay system (Promega, Madison, WI), according to the manufacturer's instructions. Transfection efficiency was normalized on the basis of ␤-galactosidase (␤-gal) activity expressed from cotransfected pCMV/␤-gal plasmids (Promega). The relative luciferase activities presented reflect triplicate values from a representation of no less than three independent experiments.
Coprecipitation assays
293T cells (1ϫ10 5 ) were cotransfected with Flag-tagged GATA-2 constructs and His-p300 -HAT/pCDNA. His-p300 -HAT in cell lysates was precipitated with BD Talon resin (Clontech, Palo Alto, CA) as per the manufacturer's instruction. Precipitates were subjected to SDS-PAGE followed by immunoblot with anti-Flag antibody.
Generation of cells expressing GATA-2/ER
The His-GATA-2/ER/pCDNA and the mutant constructs disrupted at the acetylated lysines were electropolated into 32D cells with gene pulser (BioRad, Hercules, CA) at 300 V and 960 F. Single-cell clones were isolated by limiting dilution with selection by 800 g/mL geneticin (Sigma Chemical Co., St. Louis, MO) and were maintained for further analysis.
RESULTS
GATA-2 is acetylated by p300 and GCN5
To examine whether GATA-2 is acetylated in vivo, we pulselabeled KG1 cells, which express GATA-2 at a relatively high level, with To test whether a panel of known acetyltransferases can acetylate GATA-2, we performed an in vitro acetylation assay using bacterially expressed GATA-2 fused to GST. GST-fused recombinant polypeptides representing the HAT domain of p300 (encompassing aa 1053-1810) and the full-length GCN5 were generated and designated as p300 -HAT and GCN5, respectively. Both HATs acetylated GATA-2 in vitro ( Fig.  2A) . We further generated recombinant GST proteins fused to three parts of GATA-2 corresponding to aa 1-197, 198 -393 , and 393-480 and designated as G2 Wild, G2(198-393)Wild, and G2(393-480)Wild, respectively. Whereas p300 -HAT acetylated these three domains of GATA-2 almost equally, GCN5 predominantly acetylated the C-terminal domain of GATA-2 more than the other two (Fig. 2B) . These results indicate that the sites of acetylation of GATA-2 by p300 differ from those acetylated by GCN5.
GATA-2 acetylation by p300 occurs at multiple sites
Having established that GATA-2 is acetylated in vivo and in vitro, we set out to dissect the location of these acetylation sites within GATA-2. In the case of GATA-1, lysine-to-alanine substitutions of two KXKK motifs at the C-terminal tails of both zinc fingers abrogated its acetylation almost completely [22] . The data from in vitro acetylation assay using partial GATA-2, however, clearly showed that GATA-2 had another acetylation site by p300 outside the zinc finger domain (Fig. 2B ). To map the acetylation sites of GATA-2 by p300, we substituted various lysine residues, including those outside the zinc finger domain, for alanine one at a time or neighboring ones together and assigned a number to these mutations from M1 to M11 (Fig. 3A) . We introduced these mutations into our GATA-2 constructs in various combinations and designated these constructs with mutation numbers. For example, substitution of lysine 334 and 336 for alanine was designated as M7, and the GATA-2 construct (aa 198 -393) with M7 was designated as G2(198-393)M7 (Fig. 3B ).We performed in vitro acetylation assays using these constructs. In these assays, M1 decreased the p300 -HAT-induced acetylation of the N-terminal part of GATA-2 (aa 1-197) to 12% of that of wild-type GATA-2, indicating that lysine 102 was a major acetylation site within this domain, although M2 also reduced the acetylation to 58% (Fig. 3C, left panel) . In the middle part of GATA-2 (aa 198 -393), M7 caused a reduction in acetylation to 72% of the wild-type GATA-2, and a further reduction to 56% was obtained by the addition of M5. Finally, the acetylation was reduced to 11% by the further addition of M9, whereas the addition of M3, M4, M6, or M8 had no effect or actually increased the intensity of the acetylation (Fig. 3C, center  panel) . On the whole, M11 reduced the acetylation of the C-terminal part of GATA-2 (aa 393-480) to 26% of the wildtype level. By a further introduction of M10, the acetylation intensity was reduced to 6% (Fig. 3C, right panel) . From these results, we concluded that M1, M5, M7, M9, M10, and M11 disrupted the major p300 acetylation sites in GATA-2.
Next, we introduced the mutations that reduced acetylation in our GATA-2 subdomains into full-length GATA-2. The acetylation-defective mutants of GATA-2 in the N-terminal part (M1), middle part (M5, M7, and M9), C-terminal part (M10 and M11), and all of three parts together were designated as G2M1, G2M5·7·9, G2M10·11, and G2M all, respectively (Fig.  3D ). In the acetylation assay using these full-length GATA-2 ) were pulse-labeled with [ 14 C]acetate for 4 h. Nuclear extracts of these cells were immunoprecipitated with rabbit anti-GATA-2 antibody (anti-GATA-2 R Ab) or control rabbit IgG. Ninety percent of each immunoprecipitate was subjected to SDS-PAGE and autoradiography (upper panel), and 10% of that was subjected to Western blot (WB) analysis using mouse anti-GATA-2 antibody (anti-GATA-2 M Ab; lower panel). The arrows indicate the position of GATA-2 in both panels. The positions of molecular mass markers are shown. mutants fused to GST, the acetylation of GST-G2M1, GST-G2M5·7·9, and GST-G2M10·11 by p300 -HAT was reduced to 85%, 50%, and 50% of the wild-type level, respectively, and the combined GST-G2M all mutant showed no detectable acetylation (Fig. 3E) . These results indicate that GATA-2 is acetylated at the lysine residues replaced in M1 (lysine 102), M5 (lysines 281 and 285), M7 (lysines 334 and 336), M9 (lysines 389 and 390), M10 (lysine 399), and M11 (lysines 403, 405, 406, 408, and 409), referred to below as K1, K5, K7, K9, K10, and K11, respectively, and that the lysines 179, 419, and 424, untested in these experiments, are unlikely to have a substantial role in the acetylation of GATA-2. We compared the amino acid sequences flanking these acetylation sites among the different GATA family proteins. They are completely conserved in GATA-2 among a broad variety of different species (Fig. 3D ).
Lysines acetylated in GATA-2 in vivo largely parallel those acetylated in vitro by p300
We examined the effect of p300 coexpression on GATA-2 acetylation in vivo by the use of 293T cells transfected with Flag-tagged, wild-type GATA-2. Cells were labeled with [ 14 C]acetate. Then, GATA-2 in the cell lysate was immunoprecipitated with anti-Flag M2 antibody and subjected to SDS-PAGE. The autoradiograph showed that GATA-2 was acetylated endogenously and that coexpression of p300 -HAT enhanced this GATA-2 acetylation approximately by two-to threefold; this was consistent, as revealed by repeated experiments. Representative data are shown (Fig. 4, lanes 1 and 2) . Next, to determine the sites of endogenous acetylation in vivo, we investigated the acetylation status of Flag-tagged, wild-type, and mutant GATA-2 transfected to 293T cells as described Asterisks indicate the positions of lysine-to-alanine mutations. Solid and shaded boxes represent amino-and carboxy-terminal zinc fingers, respectively. Numbers correspond to amino acids. (C) In vitro acetylation of wild-type and mutant GATA-2 subdomains. An equal amount (2 g) of wild-type or mutant GATA-2 fragments fused to GST was acetylated in vitro by GST-p300 -HAT and was subjected to SDS-PAGE, CBB staining, and autoradiography as described in Figure 2 . above. The levels of acetylation in G2M1, G2M5·7·9, and G2M10·11 were reduced to 50%, 27%, and 28% of the wildtype level, respectively. G2M all showed no detectable acetylation (Fig. 4, lanes 1, 3-6 ). Equal efficiency of immunoprecipitation among all GATA-2 constructs was confirmed by WB analysis with anti-GATA-2 antibody (middle panel). These results indicate that p300 can induce acetylation of GATA-2 in vivo and that acetylation of GATA-2 in intact cells occurs at sites similar to those induced by p300 in vitro.
Acetylation increases DNA-binding activity of GATA-2
Having identified the acetylation sites of GATA-2, we set out to dissect the functional consequence of GATA-2 acetylation. By electrophoretic mobility shift assay (EMSA), we first tested whether acetylation of GATA-2 affects its DNA-binding activity. The purified GST-G2Wild was incubated with radiolabeled oligomers containing cognate GATA sites. The obtained single band was competed by the presence of a 200-fold molar excess of nonradiolabeled oligomers and was supershifted by anti-GST antibody but not by control goat IgG (Fig. 5A) . Increasing amounts (50 ng, 100 ng, 150 ng, 200 ng each) of GST-G2Wild and 50 ng GST-p300 -HAT were incubated with or without acetyl-CoA and were then subjected to EMSA. Acetylation by p300 -HAT in vitro elevated DNA-binding activity of GATA-2 by approximately threefold (Fig. 5B) . We also compared DNAbinding activity between GATA-2 incubated with p300 -HAT and that without p300 -HAT in the presence of acetyl-CoA and obtained almost similar results (data not shown). Next, to investigate the influence of the acetylated lysines identified above on the DNA-binding activity of GATA-2, our acetylation-defective mutants of GATA-2 were subjected to EMSA. M1 and M10·11 had no significant effect on DNA-binding activity of GATA-2, but M5·7·9 and M all reduced the activity to 47.5% and 21.5% of wild-type level, respectively (Fig. 5C) . In addition, we tested whether DNA-binding activity of GATA-2 was altered by the acetylation by p300 in wild-type and these defective mutants. Strikingly, the DNA-binding activity was minimally affected by p300 incubation of the acetylation-defective mutants, whereas the binding activity of the wild-type GATA-2 was consistently increased by p300, as revealed by the three independent experiments (Fig. 5D) . These results indicate that p300 regulates the DNA-binding activity of GATA-2 through acetylation of the lysines we identified.
Acetylation enhances transactivating potential of GATA-2
We next asked if acetylation modified the transactivating potential of GATA-2. To examine the effect of acetylation on GATA-2-dependent, transactivating capacity, we performed a luciferase assay using promoter-bearing GATA-binding motifs. As shown in Figure 6A , coexpression of p300 -HAT with G2Wild further boosted reporter gene activation by G2Wild alone by 5.8-fold (lane 4). To further examine the influence of acetylated lysines in GATA-2 on its transactivating potential, our GATA-2 lysine-to-alanine mutants were tested in the luciferase assay. G2M1 showed reduced transactivation potential, 33% of the wild-type level, whereas all the other mutants completely abrogated the transactivating potential (Fig. 6B) . Furthermore, we examined the effect on GATA-2 transactivation by coexpression of p300 -HAT. Whereas p300 consistently elevated wild-type GATA-2-dependent transactivation, all mutants were severely impaired in their response to p300 (Fig. 6C) . These results establish the importance of acetylated lysines in regulation of GATA-2 transactivity by p300. Moreover, the fact that M1 and M10·11 abolished GATA-2 transactivity without impairment of DNA-binding activity indicates that p300 affects GATA-2 transactivating potential by mechanisms in addition to regulation of DNA-binding activity.
To further elucidate the mechanism by which p300 regulates the transactivation potential of GATA-2, we examined whether our acetylation-defective mutations affected the interaction between GATA-2 and p300 -HAT in 293T cells. Flag-tagged wild-type and mutant GATA-2 were coprecipitated with Histagged p300 -HAT at almost the same efficiency (Fig. 6D,  upper panel) . Immunoblot of precipitates with anti-His antibody and that of inputs with Flag antibody, respectively, confirmed the efficiency of p300 -HAT precipitation and GATA-2 expression levels to be equal among each sample (Fig. 6D , lower panel, and data not shown). Taken together with the fact that acetylation-defective mutations abolish GATA-2 transactivity, altered protein interaction with p300 is not exclusively responsible for the abrogated transactivation of acetylationdefective mutants of GATA-2. These data indicate that acety- lation by p300 may regulate GATA-2 transcriptional activity through mechanisms other than the altered DNA-binding or p300 interaction.
Acetylation can affect the growth-inhibiting effect of GATA-2
An in-frame fusion of GATA-2 and the ligand-binding domain of ER generate an estrogen-inducible form of GATA-2 (GATA-2/ER) [40] . The mechanism of this inducible transactivation has been attributed to a ligand-dependent unmasking of the transactivation domain(s) of GATA-2/ER. We therefore fused ER to the C-terminal of His-tagged GATA-2 and the mutants G2M1, G2M5·7·9, G2M10·11, and G2M all; these are designated as G2Wild/ER, G2M1/ER, G2M5·7·9/ER, G2M10·11/ ER, and G2M all/ER, respectively. To reveal the biological significance of GATA-2 acetylation, we transfected these ERfusion constructs into 32D cells, IL-3-dependent early myeloid progenitor cells, by electroporation. Single clones of stable transfectants were established by selection with 800 g/ml geneticin in the presence of IL-3. WB analyzed the expression of GATA-2/ER of five clones from each construct. One representative clone from each mutant with the strongest expression of GATA-2/ER was designated as G2Wild/ER 32D, G2M1/ER 32D, G2M5·7·9/ER 32D, G2M10·11/ER 32D, and G2M all/ER 32D, respectively, and subjected to further analysis. The GATA-2/ER expression of these clones is shown (Fig. 7A) . In murine IL-3-dependent, multipotential, hematopoietic progenitor, factor-dependent, cell-Patersen (FDCP)-mix cells, the upregulation of GATA-2/ER by estrogen resulted in arrested growth and an enhanced differentiation down the granulomonocytic pathway that occurred despite the presence of an IL-3-mediated self-renewal signal [41] . Consistent with this, G2Wild/ER 32D grew slowly under 0.2 M ␤-estradiol. The viable cell number after 4 days in ␤-estradiol was only 24% of that without ␤-estradiol, and ␤-estradiol had no effect on the growth of parental 32D cells (Fig. 7, B and C) . The viability of the cells was consistently over 90% regardless of the addition of ␤-estradiol (data not shown). No significant, morphological change was obtained in the cells stained by May-Giemsa (data not shown). Having established that GATA-2 has a growthinhibiting effect on 32D cells, our mutant GATA-2/ER transfectants were subjected to the same assay to test the role of Fig. 6 . Enhanced transactivating potential of GATA-2 by acetylation. (A) 293T cells (1ϫ10 5 ) were transfected with GATA reporter gene in the presence (ϩ) or absence (-) of wild-type GATA-2 expression vector and His-p300 -HAT expression vector as indicated. Cell lysates were prepared 48 h after transfection and were assayed for luciferase activity. The relative luciferase activities presented reflect triplicate values from a representation of no less than three independent experiments. (B) 293T cells were transfected with GATA reporter gene and empty vector (-) or GATA-2 expression vectors as indicated and were subjected to luciferase assay. The relative luciferase activities presented reflect triplicate values from a representation of no less than three independent experiments. (C) GATA reporter gene and empty vector (-) or GATA-2 expression vectors as indicated were transfected to 293T cells with or without p300 -HAT expression vector, and cells were subjected to luciferase assay. Three independent experiments were performed. The average of the fold increase in the activity derived from each GATA-2 construct in the presence of p300 -HAT relative to that from respective GATA-2 constructs in the absence of p300 -HAT is shown with standard deviation. (D) 293T cells (1ϫ10 5 ) were transfected with empty vector (-) or Flag-tagged GATA-2 constructs in the presence (ϩ) or absence (-) of cotransfection of His-tagged p300 -HAT expression vector. His-tagged p300 -HAT was purified with BD Talon resin and subjected to SDS-PAGE. GATA-2 bound to p300 -HAT was detected by immunoblot with anti-Flag antibody. Two independent experiments were performed. Representative image is shown. Arrows indicate GATA-2 bound to p300. acetylation in the biological function of GATA-2. The growthinhibiting effect of GATA-2/ER was drastically impaired by the mutation of the acetylated lysines. Specifically, the cell numbers of G2M1/ER 32D, G2M5·7·9/ER 32D, G2M10·11/ER 32D, and G2Mall/ER 32D cultured with ␤-estradiol relative to those without ␤-estradiol were 85%, 105%, 73%, and 100%, respectively (Fig. 7C) . The growth curves of these transfectants cultured in the presence or absence of ␤-estradiol were almost identical to those of parental 32D cells with or without ␤-estradiol and G2Wild/ER 32D without ␤-estradiol (data not shown). These results indicate that GATA-2 has a growthinhibiting effect on 32D cells and that acetylation appears to enhance this biological function of GATA-2.
DISCUSSION
The major conclusion from this work is that acetylation may modulate a number of functional properties of GATA-2, including DNA-binding activity and transactivating potential. Whereas phosphorylation of transcription factors has been shown to be a critical, post-translational modification that regulates DNA-binding activity, nuclear localization, protein interaction, and transactivation, functional regulation of transcription factors by acetylation has not been fully understood. However, as the list of acetylated transcription factors has grown, more knowledge is being accumulated. DNA-binding activity is increased by acetylation of p53 [12, 13] , E2F [17] , c-Myb [18, 19] , and HNF-4 [20] , whereas acetylation reduces or has no effect on DNA-binding activity of high mobility group I(Y) [49] , EKLF [14] , and Sp1 [15] , respectively. The reported effect of acetylation on GATA-1 DNA binding, however, has been controversial; i.e., one report indicates an increase in DNA binding by acetylation through p300 [21] , whereas another report indicates no alteration in DNA-binding capacity by acetylation through CBP [22] . We show in the present study that the acetylation by p300 enhances the DNA-binding potential of GATA-2. It will need to be further clarified whether the cause of this differential effect of acetylation on DNAbinding potential between GATA-1 and GATA-2, if any, is a result of the difference in acetylated motifs, i.e., outside the zinc finger domain (K1), or the difference of HAT (p300 vs. CBP) as suggested by the authors [22] . Acetylation of GATA-1 by p300 and CBP occurs at the C-terminals of two zinc fingers corresponding to GATA-2 acetylation sites K7, K10, and K11 [21, 22] . Mutations of these acetylated lysines reduced association of GATA-1 with CBP [22] , whereas we have shown that the acetylated lysines are not required for association of GATA-2 with p300. This suggests that acetylation may have a different effect on the association of p300/CBP with GATA-1 compared with GATA-2. Furthermore, GATA-2 has additional acetylation sites, K1, K5, and K9. K1, which seemed to be a particularly interesting lysine, is not conserved in GATA-1 but is conserved among GATA-2 of different species. We demonstrated that K1 is required for regulation of DNA-binding activity and transcriptional activity by acetylation. These results also support the existence of the differential effect(s) of acetylation between GATA-1 and GATA-2. It has also been shown that p300 and GCN5 induce acetylation of GATA-2 at the different sites. Taken together with the fact that p300 and P/CAF interact with each other, it is possible that the acetylation of GATA-2 at multiple sites by a p300/GCN5 complex may be required for full activation. Our acetylation-defective mutants of GATA-2 may provide useful tools for a future elucidation of the relevance of this type of coactivator complex in control of GATA-2 function.
We have demonstrated that GATA-2 transactivating potential can be modulated by p300 coexpression. Our data suggest that p300 may regulate GATA-2 transactivation through regulation of its DNA binding by acetylation. The mechanism(s), however, has not been fully resolved. One putative mechanism by which p300 may regulate the activity of transcription factors is acetylation of the adjacent histones, leading to an increase in accessibility of the chromatin for the transcriptional machinery or additional cofactors. Acetylation-defective mutants of GATA-2, which retain binding ability to p300 in vivo, did not respond to p300 in the present reporter assay (Fig. 6, C and D) , suggesting that histone acetylation by p300 is not the main determinant of up-regulation of GATA-2 transactivation in our system. Several other proteins, however, are speculated to associate with GATA-2 and affect its transactivation such as friend of GATA, promyelocytic leukemia protein, PU.1, activation protein-1 (AP1), and Pit1 [48, 50 -52] . Acetylation might regulate an association of GATA-2 with these candidate accessory proteins (or unknown proteins), resulting in the altered transcriptional activity of GATA-2 we observe. Acetylation of lysine residues neutralizes their positive charge and changes the size of the residues. Such changes conceivably can confer alterations in protein function comparable with those that occur upon phosphorylation. We have reported such an example in the case of c-Myb acetylation, where acetylation may lead to neutralizing of the positive charge, resulting in altered DNA-binding activity [18] . Alternatively, acetylation could directly influence protein-DNA interactions or proteinprotein interactions, as has been suggested for the binding of histone tails to DNA [1, 2] or to the yeast transcriptional repressor Tup1 [53] . It is conceivable that acetylation leads to a conformational change in GATA-2, thereby increasing activity through exposure of the DNA-binding domain and putative activation domain. Furthermore, the docking sites for still undefined coactivators might be exposed by the acetylation. It might be argued that in vitro conditions might not reflect the actual changes in GATA-2 function triggered by acetylation. However, the fact that the lysines acetylated in vitro by our assay are highly conserved among different species together with our demonstration of the coincidence of acetylation sites determined by in vitro to those in vivo strengthen the likelihood that these acetylation domains play an important role in vivo as well as in vitro. The specific roles of these different acetylation sites in the crucial in vivo cell functions of GATA-2 are still unknown, although individual mutations of each individual acetylation motif in GATA-2, i.e., from K1 to K11, diminished its function in vivo to some extent.
As crucial GATA-2 functions have been primarily identified in immature hematopoietic stem cells, the methodology for examining GATA-2 functions in vivo is somewhat limited. One possible solution is to use the GATA-2/ER system as applied in the present study. The in vivo functional analysis clearly indicates that every site of lysine acetylation tested is involved to some degree in GATA-2-directed growth inhibition. The exact mechanism remains to be elucidated by which acetylation of GATA-2/ER exerts its function in ER-dependent cell growth inhibition in IL-3-dependent hematopoietic progenitor cells. One possible mechanism of growth inhibition by GATA-2 is the transactivation of a GATA-2 target gene, which in turn mediates growth inhibition; the specific target gene of GATA-2 involved in this phenomenon remains to be identified. It is interesting that although G2M10·11 showed no detectable transactivation activity, it still inhibited the growth of 32D cells, reducing them to 73%. This suggests that GATA-2 might have additional mechanisms for growth inhibition beyond transactivation of the target gene studied here. GATA-2 has been shown to associate with other transcription factors such as AP1 and PU.1 and to regulate their transactivation activity positively or negatively [50, 51] . One of the mechanisms of GATA-2 for growth inhibition may be a functional modulation of these or other transcription factors related to cell growth. A detailed examination of the expected alteration of DNA-binding activity and transcriptional activity caused by acetylationdefective mutations in the GATA-2/ER system may further confirm our claims. Recently, it has been shown that the functions of GATA-2/ER in embryonic hematopoiesis are somewhat different from those of GATA-2 [54] . In committed progenitor cells, however, GATA-2 and GATA-2/ER are reported to have inhibitory effects to hematopoiesis, which is consistent with our finding in 32D cells [41, 42] . In addition, another group has found the growth-inhibitory effects of GATA-2/ER in a very similar system as ours [55] .
Thus, taken together, our data suggest that acetylation regulates the GATA-2 function at multiple levels. Acetylation has been generally shown to regulate DNA-binding activity, protein interaction, nuclear localization, protein stability, and transactivation activity of the transcription factor. The putative mechanism of these regulations is a conformational change as a result of neutralization of the positive charge of lysine residue by acetylation. In this study, we revealed that acetylation regulates the DNA-binding potential and transactivating potential of GATA-2 and consequently, at least some of its biological functions. More extensive analyses will be required to elucidate additional functions of GATA-2 that may be reg-ulated by acetylation. These may include structural analysis, detection of a functional partner whose association with GATA-2 is regulated by acetylation, and a differentiation assay using GATA-2Ϫ/Ϫ hematopoietic stem cells rescued by GATA-2 with mutations of acetylated lysines. The generation of specific high-affinity antibody that recognizes the acetylated form of endogenous GATA-2 protein will be useful in addressing this issue. What our results demonstrate is that acetylation represents a novel mechanism by which the activity of GATA-2 is regulated.
